Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
School of Laboratory Medicine and Life Sciences
Kefang Liu has not added Biography.
If you are Kefang Liu and would like to personalize this page please email our Author Liaison for assistance.
Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy.
Cell research Jan, 2017 | Pubmed ID: 27573173
Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies.
Protein & cell Dec, 2016 | Pubmed ID: 27815822
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
Antiviral research 01, 2017 | Pubmed ID: 27840203
Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.
Journal of immunology (Baltimore, Md. : 1950) 01, 2017 | Pubmed ID: 27903740
Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab.
Protein & cell Jan, 2018 | Pubmed ID: 28488247
Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses.
mBio Aug, 2018 | Pubmed ID: 30087171
Divergent Peptide Presentations of HLA-A30 Alleles Revealed by Structures With Pathogen Peptides.
Frontiers in immunology , 2019 | Pubmed ID: 31396224
Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.
PLoS biology 09, 2019 | Pubmed ID: 31498797
Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.
Journal of virology 08, 2020 | Pubmed ID: 32522857
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2.
Cell discovery , 2020 | Pubmed ID: 33020722
N-glycosylation of PD-1 promotes binding of camrelizumab.
EMBO reports 12, 2020 | Pubmed ID: 33063473
Cross-species recognition of SARS-CoV-2 to bat ACE2.
Proceedings of the National Academy of Sciences of the United States of America 01, 2021 | Pubmed ID: 33335073
Wenzhou Medical University
Chinese Center For Disease Control And Prevention
Chinese Academy of Sciences
University of Macau
Yongli Zhang*,1,2,
Hangjie Zhang*,2,
Wenqiang Ma*,3,
Kefang Liu1,2,
Min Zhao4,
Yingze Zhao2,
Xuancheng Lu5,
Fuping Zhang6,
Xiangdong Li3,
George F. Gao1,2,4,6,
William J. Liu1,2
1School of Laboratory Medicine and Life Sciences, Wenzhou Medical University,
2NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention,
3State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agricultural University,
4Research Network of Immunity and Health (RNIH), Beijing Institutes of Life Science, Chinese Academy of Sciences,
5Laboratory Animal Center, Chinese Center for Disease Control and Prevention,
6CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences
Di Zhang*,1,2,
Kefang Liu*,3,4,
Dan Lu*,2,5,
Pengyan Wang1,2,
Qingxu Zhang1,2,
Peipei Liu2,
Yan Chai4,
Jianxin Lyu1,
Jianxun Qi4,
2NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention,
3Faculty of Health Sciences, University of Macau,
4CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences,
5Savaid Medical School, University of Chinese Academy of Sciences
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados